A detailed history of Erste Asset Management Gmb H transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 140,225 shares of BBIO stock, worth $3.89 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
140,225
Holding current value
$3.89 Million
% of portfolio
0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.91 - $31.3 $3.35 Million - $4.39 Million
140,225 New
140,225 $3.5 Billion
Q2 2024

Nov 26, 2024

BUY
$23.0 - $31.04 $759,000 - $1.02 Million
33,000 Added 30.78%
140,225 $3.53 Billion
Q1 2024

Nov 26, 2024

BUY
$27.35 - $40.45 $629,050 - $930,350
23,000 Added 27.31%
107,225 $3.31 Billion
Q4 2023

Nov 26, 2024

BUY
$24.02 - $43.89 $384,320 - $702,240
16,000 Added 23.45%
84,225 $3.52 Billion
Q3 2023

Nov 26, 2024

BUY
$16.89 - $35.01 $506,700 - $1.05 Million
30,000 Added 78.48%
68,225 $1.85 Billion
Q1 2023

Nov 26, 2024

BUY
$7.17 - $18.55 $215,100 - $556,500
30,000 Added 78.48%
68,225 $1.17 Billion
Q3 2022

Nov 26, 2024

SELL
$7.94 - $12.36 $809,880 - $1.26 Million
-102,000 Reduced 72.74%
38,225 $390 Million
Q2 2022

Nov 26, 2024

SELL
$5.21 - $12.14 $531,420 - $1.24 Million
-102,000 Reduced 72.74%
38,225 $338 Million
Q1 2022

Nov 22, 2024

SELL
$7.34 - $17.16 $139,460 - $326,040
-19,000 Reduced 33.2%
38,225 $396 Million
Q4 2021

Nov 22, 2024

SELL
$11.38 - $53.41 $944,540 - $4.43 Million
-83,000 Reduced 59.19%
57,225 $812 Million
Q3 2021

Nov 22, 2024

SELL
$46.87 - $64.24 $899,904 - $1.23 Million
-19,200 Reduced 25.12%
57,225 $2.73 Billion
Q1 2021

Nov 22, 2024

BUY
$55.47 - $72.35 $1.08 Million - $1.41 Million
19,425 Added 34.08%
76,425 $4.52 Billion
Q3 2020

Nov 22, 2024

SELL
$27.2 - $42.19 $2.26 Million - $3.51 Million
-83,225 Reduced 59.35%
57,000 $2.11 Billion
Q4 2019

Nov 22, 2024

SELL
$17.96 - $46.63 $1.49 Million - $3.88 Million
-83,225 Reduced 59.35%
57,000 $2.1 Billion
Q3 2019

Nov 22, 2024

SELL
$20.13 - $32.38 $2.36 Million - $3.8 Million
-117,225 Reduced 83.6%
23,000 $463 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.11B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.